Curaleaf to Report Third Quarter 2025 Financial and Operational Results

Rhea-AI Summary

Curaleaf (OTCQX: CURLF), a leading international cannabis consumer products company, has scheduled its Q3 2025 earnings release for November 5, 2025, after market close. The company will host a conference call and webcast at 5:00 p.m. ET the same day.

Management will provide prepared remarks followed by a Q&A session focusing on operational and financial highlights. Investors can access the call through various dial-in numbers, with a replay available until November 12, 2025. The live webcast will be accessible through the company's investor relations website.

STAMFORD, Conn., Sept. 25, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2025 after market close on November 5, 2025.

Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights.

Event:

Curaleaf Third Quarter 2025 Financial Earnings Conference Call

Date:

Wednesday, November 5, 2025

Time:

5:00 p.m. ET

Live Call:

+1-844-512-2926 (U.S.), +1-416-639-5883 (Canada) or +1-412-317-6300 (International)

Passcode:

5064695

Webcast:

https://ir.curaleaf.com/events

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until November 12, 2025, and can be accessed by dialing +1-877-344-7529 (U.S.), +1-855-669-9658 (Canada) or +1-412-317-0088 (International) and entering replay pin number: 8603366

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Curaleaf IR X Account: https://x.com/Curaleaf_IR

Investor Relations Website: https://ir.curaleaf.com/

Investor Contact:                                                                               
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer 
IR@curaleaf.com

Media Contact: 
MATTIO Communications
MattioCuraleaf@Mattio.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-to-report-third-quarter-2025-financial-and-operational-results-302567613.html

SOURCE Curaleaf Holdings, Inc.

FAQ

When will Curaleaf (CURLF) report Q3 2025 earnings?

Curaleaf will report Q3 2025 earnings on November 5, 2025 after market close, followed by a conference call at 5:00 p.m. ET.

How can investors access Curaleaf's Q3 2025 earnings call?

Investors can access the call via U.S. dial-in (+1-844-512-2926), Canada (+1-416-639-5883), International (+1-412-317-6300), or webcast at ir.curaleaf.com/events.

What is the replay information for Curaleaf's Q3 2025 earnings call?

A replay will be available until November 12, 2025 by dialing U.S. (+1-877-344-7529), Canada (+1-855-669-9658), or International (+1-412-317-0088) with PIN: 8603366.

What topics will be covered in Curaleaf's Q3 2025 earnings call?

The call will cover Curaleaf's financial and operational highlights for Q3 2025, including prepared management remarks and a Q&A session.